Fetal growth and development in SLE patients might be threatened by disease activity, abnormality of maternal renal function, antiphospholipid antibodies, and anti-SSA/Ro and anti-SSB/La antibodies. The gene discussed is CALR; the disease is systemic lupus erythematosus.